COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 06/30/2025 | 03/31/2025 | 06/30/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.16% | -16.07% | -5.89% | -5.89% | -5.89% |
| Total Receivables | 49.70% | -24.77% | 339.94% | 339.94% | 339.94% |
| Inventory | -25.82% | -8.77% | 4,673.44% | 4,673.44% | 4,673.44% |
| Prepaid Expenses | 34.25% | -16.35% | -99.69% | -99.69% | -99.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -23.60% | 18.46% | -- | -- | -- |
| Total Current Assets | -18.92% | -15.12% | 6.45% | 6.45% | 6.45% |
|
|
|||||
| Total Current Assets | -18.92% | -15.12% | 6.45% | 6.45% | 6.45% |
| Net Property, Plant & Equipment | 2.48% | -2.80% | 4,143.17% | 4,143.17% | 4,143.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.13% | 4.07% | 514.42% | 514.42% | 514.42% |
| Total Assets | -11.51% | -11.20% | 57.41% | 57.41% | 57.41% |
|
|
|||||
| Total Accounts Payable | -46.25% | 18.65% | 49.25% | 49.25% | 49.25% |
| Total Accrued Expenses | -19.39% | -19.74% | 17.93% | 17.93% | 17.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.39% | -6.64% | 164.29% | 164.29% | 164.29% |
| Total Finance Division Other Current Liabilities | 12.36% | -5.80% | 366.16% | 366.16% | 366.16% |
| Total Other Current Liabilities | 12.36% | -5.80% | 366.16% | 366.16% | 366.16% |
| Total Current Liabilities | -20.98% | -2.26% | 88.46% | 88.46% | 88.46% |
|
|
|||||
| Total Current Liabilities | -20.98% | -2.26% | 88.46% | 88.46% | 88.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.85% | -3.24% | 1,500.00% | 1,500.00% | 1,500.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.26% | -5.40% | -6.30% | -6.30% | -6.30% |
| Total Liabilities | -2.55% | -4.16% | 26.54% | 26.54% | 26.54% |
|
|
|||||
| Common Stock & APIC | 0.43% | 0.08% | -92.50% | -92.50% | -92.50% |
| Retained Earnings | -17.55% | -21.02% | 100.41% | 100.41% | 100.41% |
| Treasury Stock & Other | -24.91% | -17.56% | -97.16% | -97.16% | -97.16% |
| Total Common Equity | -30.04% | -22.92% | 102.21% | 102.21% | 102.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.04% | -22.92% | 102.21% | 102.21% | 102.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.04% | -22.92% | 102.21% | 102.21% | 102.21% |
|
|
|||||